In a filing, Keurig Dr Pepper Inc revealed its Director Gamgort Robert James unloaded Company’s shares for reported $6.84 million on Aug 01 ’25. In the deal valued at $32.90 per share,208,000 shares were sold. As a result of this transaction, Gamgort Robert James now holds 2,292,169 shares worth roughly $78.9 million.
Then, ROBERT J. GAMGORT 1999 TRUST U bought 208,000 shares, generating $6,791,200 in total proceeds.
Before that, Gamgort Robert James sold 208,000 shares. Keurig Dr Pepper Inc shares valued at $6,901,856 were divested by the Director at a price of $33.18 per share. As a result of the transaction, Gamgort Robert James now holds 2,500,169 shares, worth roughly $86.06 million.
HSBC Securities upgraded its Keurig Dr Pepper Inc [KDP] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including Argus’s analysts, who began to cover the stock in mid April with a ‘”a Buy”‘ rating. Piper Sandler also remained covering KDP and has increased its forecast on April 09, 2025 with a “an Overweight” recommendation from previously “Neutral” rating. Morgan Stanley revised its rating on April 01, 2025. It rated KDP as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of KDP
On Friday, Keurig Dr Pepper Inc [NASDAQ:KDP] saw its stock jump 1.53% to $34.42. Over the last five days, the stock has gained 3.30%. Keurig Dr Pepper Inc shares have fallen nearly -0.17% since the year began. Nevertheless, the stocks have risen 7.16% over the past one year.
How much short interest is there in Keurig Dr Pepper Inc?
A steep rise in short interest was recorded in Keurig Dr Pepper Inc stocks on 2025-07-15, growing by 6.43 million shares to a total of 27.47 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 21.04 million shares. There was a rise of 23.4%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 07, 2025 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $35 price target.
